Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT05274087 Completed - Healthy Volunteers Clinical Trials

Study to Evaluate the Effect of Different Warm-Up Times of Risankizumab Autoinjector (AI) on the Injection Pain Experiences in Healthy Volunteers

Start date: September 15, 2020
Phase: Phase 1
Study type: Interventional

The objective of this study is to assess the impact of different warm-up times of risankizumab autoinjector (AI) on the participant injection site pain experience in healthy adult volunteers.

NCT ID: NCT05271799 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female Participants

Start date: March 1, 2022
Phase: Phase 1
Study type: Interventional

This study is a randomized, open-label, two periods, cross-over pharmacokinetic, safety, tolerability and relative bioavailability of gepotidacin in healthy adult male and female participants of aged 18 to 50 years.

NCT ID: NCT05268068 Completed - Healthy Volunteers Clinical Trials

A Study of Intravenously (IV) Infused or Subcutaneously (SC) Injected Risankizumab in Healthy Adult Participants in China

Start date: June 27, 2019
Phase: Phase 1
Study type: Interventional

The objective of this study to assess the pharmacokinetics, safety, tolerability and immunogenicity following a single subcutaneous (SC) or intravenous (IV) dose of risankizumab in healthy Chinese participants.

NCT ID: NCT05264493 Completed - Healthy Volunteers Clinical Trials

Bioavailability Study of Naloxone 5 Milligrams (mg) Intramuscular (IM) Autoinjector

Start date: October 6, 2020
Phase: Phase 1
Study type: Interventional

To compare the plasma concentration (bioavailability) and safety of a single naloxone 5 mg autoinjector intramuscular (IM) injection to a single 2 mg IM injection (an approved safe dose) and to a single 2 mg bolus intravenous (IV) injection (an approved safe dose)

NCT ID: NCT05256732 Completed - Clinical trials for Healthy Volunteer Study

Study of AT-527 in Healthy Subjects Under Fasting Conditions or With a Meal

Start date: February 22, 2022
Phase: Phase 1
Study type: Interventional

This study will assess the safety, tolerability and pharmacokinetics (PK) of AT-527 following oral administration under fasting conditions or with a meal in healthy adult subjects

NCT ID: NCT05250622 Completed - Healthy Volunteer Clinical Trials

OrthoEvidence Trial Assessing Japanese Knowledge Updates

OTAKU
Start date: April 8, 2022
Phase: N/A
Study type: Interventional

The purpose of this randomized controlled trial is to clarify whether providing translated evidence summary (Advanced Clinical Evidence (ACE) reports from OrthoEvidence) will increase the access to the summary compared to providing the original version of evidence summary among Japanese orthopaedic surgeons

NCT ID: NCT05249348 Completed - Healthy Volunteers Clinical Trials

Effect of Food on PC14586 in Healthy Volunteers and the PK of PC14586 in Healthy Japanese Volunteers

Start date: December 20, 2021
Phase: Phase 1
Study type: Interventional

This is a 2-part Phase 1 cross-over study to assess the effects of food on the pharmacokinetics of PC14586 in healthy volunteers. The pharmacokinetics of PC14586 at a clinically relevant dose in Japanese participants will also be studied.

NCT ID: NCT05246046 Completed - Healthy Volunteers Clinical Trials

Comparison of Tiotropium Absorption From Tiotropium Easyhaler and Spiriva HandiHaler

TEMPO
Start date: February 16, 2022
Phase: Phase 1
Study type: Interventional

This is a pivotal study to investigate absorption of inhaled tiotropium from 2 Tiotropium Easyhaler product variants and Spiriva capsules inhaled via HandiHaler.

NCT ID: NCT05245578 Completed - Healthy Volunteer Clinical Trials

Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects

Start date: November 16, 2021
Phase: Phase 1
Study type: Interventional

Skin Irritation and Phototoxicity Study of KX01 Ointment 1% in Japanese healthy male subjects

NCT ID: NCT05238714 Completed - Healthy Volunteers Clinical Trials

Excretion Balance, Pharmacokinetics, and Metabolism Following of [14C]-Venglustat Administration in Healthy Male Subjects

Start date: May 26, 2020
Phase: Phase 1
Study type: Interventional

Primary Objectives: - To determine the excretion balance and systemic exposure of radioactivity after oral administration of [14C]-venglustat. - To determine the pharmacokinetics (PK) of venglustat and its contribution to the overall exposure of radioactivity. - To determine the metabolic pathways, metabolite profile, chemical structures and main excretion route of the main venglustat metabolites and the metabolite contribution to the overall exposure of radioactivity. Secondary Objective: To assess the clinical and biological tolerability of oral solution of venglustat